Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.

@article{Ramalho2002FivePO,
  title={Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.},
  author={A. Ramalho and S. Beck and M. Meyer and D. Penque and G. Cutting and M. Amaral},
  journal={American journal of respiratory cell and molecular biology},
  year={2002},
  volume={27 5},
  pages={
          619-27
        }
}
  • A. Ramalho, S. Beck, +3 authors M. Amaral
  • Published 2002
  • Biology, Medicine
  • American journal of respiratory cell and molecular biology
Estimates of the level of transcripts from the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) gene required to develop a CF phenotype range from 4-20% of normal. Due to the importance of obtaining reliable data on this issue for therapeutic strategies, we developed a novel polymerase chain reaction-based method to quantify CFTR transcripts and applied it to the analysis of nasal epithelium RNA of five patients with CF and the 3272-26A>G/F508del genotype. We calculated that 8.2… Expand
View on PubMed
doi.org
165 Citations
Highly Influential Citations
4
Background Citations
54
Results Citations
6

165 Citations

Citation Type

Citation Type

Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis
  • 16
  • PDF
Pharmacological Rescue of Mutant CFTR Function for the Treatment of Cystic Fibrosis
  • 11
CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis.
  • 100
Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides
  • 47
  • PDF
Functional stability of rescued delta F508 cystic fibrosis transmembrane conductance regulator in airway epithelial cells.
  • 53
Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
  • 5
  • PDF
Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.
  • 33
  • PDF
The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation.
  • 6
CFTR and Cystic Fibrosis: From Structure to Function
  • 1
What’s new in cystic fibrosis? From treating symptoms to correction of the basic defect
  • 80
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 48 REFERENCES
The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.
  • 162
Cystic fibrosis patients with the 3272‐26A→G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane
  • 62
  • PDF
A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
  • 146
  • PDF
A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.
  • 407
A 32‐bp deletion (2991del32) in the cystic fibrosis gene associated with CFTR mRNA reduction
  • 9
Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens.
  • 92
  • PDF
Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes: a large European study
  • 42
Identification of a splice site mutation (2789+5 G>A) associated with small amounts of normal CFTRmRNA and mild cystic fibrosis
  • 82
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
  • 487
Complex cystic fibrosis allele R334W‐R1158X results in reduced levels of correctly processed mRNA in a pancreatic sufficient patient
  • 25
...
1
2
3
4
5
...